ICCM
HEALTHCAREIcecure Medical
AI Insight
What's Moving ICCM Today?
No stock-specific AI insight has been generated for ICCM yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.12$42.00
$6.07
Fundamentals
Market Cap$15M
P/E Ratio—
EPS$-7.15
Dividend Yield—
Dividend / Share—
ROE-217.2%
Profit Margin—
Debt / Equity—
Trading
Volume8.4M
Avg Volume (10D)—
Shares Outstanding2.8M
ICCM News
23 articles- IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast CancerYahoo Finance·Jun 23, 2026
- IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional InvestorYahoo Finance·Jun 17, 2026
- ICCM Stock On Track For Best Day In Nearly 5 Years — What’s Driving The 200% Rally?Stocktwits·Jun 17, 2026
- IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA ClearanceYahoo Finance·Jun 17, 2026
- IceCure consolidates shares 30-to-1 in bid to keep Nasdaq listingStock Titan·Jun 2, 2026
- IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq CompliancePR Newswire·Jun 2, 2026
- Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ...Yahoo Finance·May 21, 2026
- IceCure's ProSense® Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class OverbookedYahoo Finance·May 19, 2026
- ICCM Maintained by Maxim Group -- Price Target Lowered to $1.00GuruFocus·May 15, 2026
- Maxim Group Maintains Icecure Medical(ICCM.US) With Buy Rating, Cuts Target Price to $1Moomoo·May 15, 2026
- Icecure granted 180-day extension by Nasdaq to regain compliance with minimum bid requirementwww.marketscreener.com·May 14, 2026
- IceCure (ICCM) Q1 2026 Earnings TranscriptMotley Fool·May 12, 2026
- IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 12, 2026
- IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North AmericaYahoo Finance·May 12, 2026
- The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 7, 2026
- IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026Yahoo Finance·May 6, 2026
- IceCure Showcases ProSense® Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. MarketYahoo Finance·May 5, 2026
- IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025Yahoo Finance·Apr 21, 2026
- IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private PlacementYahoo Finance·Mar 26, 2026
- IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free RatesBenzinga·Mar 25, 2026
- IceCure Appoints Meir Peleg as Chief Financial OfficerYahoo Finance·Mar 24, 2026
- Icecure Medical Ltd (ICCM) Q4 2025 Earnings Call Highlights: Record Sales and Strategic U.S. ...Yahoo Finance·Mar 21, 2026
- IceCure Medical (ICCM) Q4 2025 Earnings TranscriptMotley Fool·Mar 17, 2026
All 23 articles loaded
Price Data
Open$6.56
Previous Close$5.93
Day High$7.25
Day Low$5.70
52 Week High$42.00
52 Week Low$2.12
52-Week Range
$2.12$42.00
$6.07
Fundamentals
Market Cap$15M
P/E Ratio—
EPS$-7.15
Dividend Yield—
Dividend / Share—
ROE-217.2%
Profit Margin—
Debt / Equity—
Trading
Volume8.4M
Avg Volume (10D)—
Shares Outstanding2.8M
About Icecure Medical
IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for the women's health and oncology markets. The company is headquartered in Caesarea, Israel.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—